State BOP

GLP-1 Compounding Rules, Board Membership, Renewal Info

The Wisconsin Pharmacy Examining Board newsletter advises pharmacies dispensing compounded GLP-1 medications (such as semaglutide or tirzepatide) to ensure compliance with Wis. Admin. Code ch. Phar 15 requirements, including facility, process, documentation, and verification standards. The newsletter references FDA guidance warning that compounders may not produce drugs essentially copies of FDA-approved drugs unless documented shortages apply. The newsletter also announces the upcoming license renewal period opening April 12, 2026 and closing May 31, 2026, and notes that 2025 WI Act 167 will add two pharmacy technician seats to the Board.

Office Closed for Good Friday

The West Virginia Board of Pharmacy announced its office will be closed on Friday, April 3, 2026 in observance of Good Friday. No regulatory actions or compliance deadlines are affected by this closure.

CSMP Modernization: Transition to RxGov Platform

The West Virginia Board of Pharmacy is modernizing its Controlled Substances Monitoring Program (CSMP) by transitioning from the legacy CSAPP platform to RxGov at pmpwv.rxgov.com. This upgrade aims to improve system performance, enhance data quality, and provide more robust reporting capabilities for all users. User manuals for RxGov are available under the FAQs section.

Justin Lachance Pharmacist Emergency Suspension

The New Hampshire Board of Pharmacy issued an emergency suspension order for pharmacist Justin Eric Lachance following evidence that he posed an imminent threat to public health, safety, or welfare. The license was suspended on February 18, 2026, after the Board reviewed a verified petition filed by OPLC Enforcement on February 17, 2026. A full adjudicative hearing was held on March 3, 2026, to determine whether the emergency suspension should remain in effect pending a complete investigation into potential controlled substance violations.

Iowa Board of Pharmacy Adopts UMPJE Exam, Updates PMP Access

The Iowa Board of Pharmacy announced the adoption of the Uniform Multistate Pharmacy Jurisprudence Exam (UMPJE) effective April 1, 2026, and updated access policies for its Prescription Management Program (PMP). Pharmacist access to the Rx Management tool is now restricted to those with a DEA registration number, and data submissions missing a prescriber's DEA number will be flagged as errors.

Iowa Board of Pharmacy Newsletter October 2025

The Iowa Board of Pharmacy newsletter for October 2025 announces new board members and updates on expanded authority for statewide protocol development. It also details changes to business license application processes allowing retention of existing license numbers and notes that Long-Term Care Facilities and Assisted Living Facilities no longer require CSA registration.

Iowa Board of Pharmacy Newsletter: Rule Review and PMP Changes

The April 2025 Pharma Phacts newsletter from the Iowa Board of Pharmacy details ongoing administrative rule reviews mandated by Executive Order 10. Two chapters have been republished under Amended Notices of Intended Action following public comment, with a comment period closing March 25, 2025. The newsletter also notes the Board of Pharmacy rules are moving to Agency ID 481 under the Department of Inspections, Appeals, and Licensing (DIAL).

Iowa Board of Pharmacy Newsletter: Rule Delays, MPJE Update, New Board Members

The Iowa Board of Pharmacy announced a 70-day administrative delay for adopted rules that would have rescinded and created new chapters in the Iowa Administrative Code. Despite this delay, the Multistate Pharmacy Jurisprudence Examination (MPJE) content will reflect the new rules effective August 1, 2025, to prepare new graduates and out-of-state pharmacists for eventual implementation.

Kansas Adopts Uniform MPJE for Pharmacist Licensure

The Kansas Board of Pharmacy has adopted the Uniform Multistate Pharmacy Jurisprudence Examination (MPJE) for pharmacist licensure, effective April 1, 2026. New graduates and pharmacists transferring licenses will be required to pass the Uniform MPJE, with the previous Kansas MPJE being discontinued at the end of 2026.

KS Boards of Pharmacy and Healing Arts Joint Statement on IV Therapy Clinics

The Kansas Boards of Pharmacy and Healing Arts have issued a joint statement addressing concerns about patient safety and regulatory compliance in retail IV therapy clinics. The statement clarifies that IV therapy is a medical practice requiring licensed professionals and outlines the Boards' investigative and referral processes for complaints.

Kansas Pharmacy Technician Renewal Deadline and Requirements

The Kansas Board of Pharmacy has issued a newsletter reminding pharmacy technicians of the October 31, 2025 renewal deadline. Technicians must complete 20 hours of continuing education and can request a six-month extension if they cannot pass the certification exam by the deadline. Failure to renew will result in registration cancellation and requires a new application process.

Kansas Board of Pharmacy Named 2025 Wellbeing First Champion

The Kansas Board of Pharmacy has been recognized as a 2025 Wellbeing First Champion for removing stigmatizing language from its licensing and renewal applications related to mental health. The Board is also initiating a stakeholder process to solicit feedback on its rules and regulations, with submissions due by October 31, 2025.

KS Board of Pharmacy: Proposed Regulation Changes and Updates

The Kansas Board of Pharmacy is proposing changes to administrative regulations, including K.A.R. 68-5-17 and 68-7-26, and revoking K.A.R. 68-1-1a. The newsletter also reminds pharmacists and technicians about free CE on PMP data integrity and requests feedback on USP <797> and <795> adoption.

Andrew Merdinyan License Emergency Suspension Order

The New Hampshire Board of Pharmacy has issued an emergency suspension order for the license of Andrew Merdinyan, a Registered Pharmacy Technician. The suspension is due to findings of probable cause that the licensee engaged in conduct posing an imminent danger to public health, safety, and welfare, including admitting to taking controlled medications from a pharmacy.

Felicia Dern - Voluntary Surrender of Pharmacy Tech License

The New Hampshire Board of Pharmacy has accepted the voluntary surrender of Felicia Dern's Registered Pharmacy Technician license (PHT-130661). This action follows allegations of drug diversion and substance misuse disorder, which led to her termination from Rite Aid.

Walmart Pharmacy Disciplinary Final Order

The New Hampshire Board of Pharmacy issued a disciplinary final order against Walmart Pharmacy concerning multiple locations. The order details the procedures and timelines for filing petitions for rehearing and the right to appeal the decision to the New Hampshire Supreme Court.

Andrew Merdinyan - Pharmacy Technician License Surrender

The New Hampshire Board of Pharmacy has accepted the voluntary surrender of Andrew Merdinyan's pharmacy technician license (PhT-131188) due to allegations of controlled drug diversion. Merdinyan allegedly diverted approximately 1,236 tablets/capsules from a Walgreens pharmacy.

NH Board of Pharmacy - Emergency Suspension of Pharmacist License

The New Hampshire Board of Pharmacy has issued an emergency order suspending the license of pharmacist Justin Eric Lachance. The suspension follows findings of suspected diversion of controlled substances, including Clonazepam and Zolpidem, observed via Walgreens surveillance and confessed by the licensee.

GA Board of Pharmacy Actions - February 2025

The Georgia Board of Pharmacy has issued a list of actions taken in February 2025. These actions include a voluntary cease and desist order for Steri-Tek PHWH004241 and a consent order for S2 Medical Supply, LLC (PHDME000685). Specific details on the nature of violations or penalties are not provided in this summary.

Georgia Board of Pharmacy Consent Orders and Revoked Registrations

The Georgia Board of Pharmacy has issued consent orders for Musely Compounding Pharmacy East LLC and Cornerstone Medical, Inc. Additionally, registrations for technicians Amira Jayde Brooks and Cythnia Elaine Brannon have been revoked.

Georgia Pharmacy Board Actions - January 2026

The Georgia Board of Pharmacy has issued its January 2026 Public Board Actions List. This list details enforcement actions taken against licensees, including the summary suspension of a facility's license and the lifting of a pharmacist's suspension. Specific licensee names and license numbers are provided for each action.

GA Board of Pharmacy Actions - January 2025

The Georgia Board of Pharmacy has revoked the registration of Yental Breanna Alford (PHTC051190) in its January 2025 public actions list. This action pertains to a pharmacy technician.

Georgia Pharmacy Board Actions - February 2026

The Georgia Board of Pharmacy has issued a list of actions taken in February 2026. These actions include a voluntary surrender for a technician and a consent order for a facility, Xttrium Laboratories, Inc. Specific details on the nature of the consent order and surrender are pending further documentation.

Wisconsin Pharmacy Board Updates and Rule Changes

The Wisconsin Pharmacy Examining Board issued a newsletter on September 17, 2020, providing updates on rule changes, COVID-19 variances, and enforcement actions. A key update concerns changes to administrative rules in Chapter Phar 7, effective January 1, 2021.

Wisconsin Pharmacy Board Rule Changes

The Wisconsin Pharmacy Examining Board has updated Chapter Phar 7, concerning the Practice of Pharmacy, with changes effective January 1, 2021. These updates were adopted on June 4, 2020, and provide important information for licensees regarding pharmacy practice regulations.

Wisconsin Pharmacy Board Activities: PDMP, HOPE, Opioid Treatment

The Wisconsin Pharmacy Board is providing an update on its activities, including the implementation of the Prescription Drug Monitoring Program (PDMP), participation in the Heroin, Opiate Prevention and Education (HOPE) legislation, and significant rewrites of Chapters 7 (Pharmacy Practice) and 15 (Sterile Pharmaceuticals) of its rules. The PDMP has seen substantial provider registration and inquiry volume, aiming to curb controlled substance abuse.

Wisconsin Pharmacy Board Rule Updates and Enforcement Actions

The Wisconsin Pharmacy Examining Board has updated administrative rules effective August 1, 2020, affecting rule chapters Phar 6 (Storage) and Phar 17 (Internships). These updates include adoption orders outlining specific changes to storage requirements and internship regulations for licensed pharmacists and interns in Wisconsin.

Kentucky Board of Pharmacy Suspends Wilson Family Pharmacy

The Kentucky Board of Pharmacy has issued an emergency suspension order for Wilson Family Pharmacy INC and pharmacist owner Jigna G Patel, effective August 15, 2025. The suspension follows preliminary findings of serious violations, including inadequate security of prescription drugs and dispensing medication without valid prescriptions, posing an imminent risk to public health.

Kentucky Pharmacy Technician Regulations Updated

The Kentucky Board of Pharmacy has updated regulations concerning pharmacy technicians, specifically 201 KAR 2:045 and 2:165. These amendments clarify technician roles, delegate new responsibilities to certified technicians, and centralize initial application requirements, including mandatory registration for an NABP e-profile.

KY Board Fines Med Save Pharmacy $5,000, Revokes Licenses

The Kentucky Board of Pharmacy has fined Med Save Pharmacy $5,000 and revoked its licenses following medication errors that led to the hospitalization of three pediatric patients. The pharmacy compounded misbranded and adulterated clonidine suspensions, violating multiple state statutes and regulations.

KY Board of Pharmacy Alert on Compounded GLP-1/GIP Drugs

The Kentucky Board of Pharmacy issued an alert regarding the compounding and dispensing of GLP-1/GIP drugs like semaglutide and tirzepatide from 503B outsourcing facilities. The alert clarifies when such compounding is permissible, referencing FDA guidance and court decisions concerning drug shortage lists and enforcement discretion.

WV Pharmacy Board Adopts CDC COVID-19 Vaccine Recommendations

The West Virginia Board of Pharmacy has adopted the CDC's recommendations for the 2025-2026 COVID-19 vaccines. This guidance allows pharmacists, technicians, and interns to administer vaccines to individuals aged 3 years and older, based on individual decision-making and CDC risk factor guidelines.

WV Board of Pharmacy Warns of Phone Scam Targeting Licensees

The West Virginia Board of Pharmacy has issued a warning regarding a phone scam targeting its licensees. Scammers are impersonating Board investigators, claiming disciplinary action and attempting to solicit payment over the phone. The Board reminds licensees that it will never request payment in lieu of an investigation.

DEA Extends Telemedicine Flexibilities for Controlled Medications

The DEA, in conjunction with HHS, has extended current telemedicine flexibilities for prescribing controlled medications through December 31, 2026. This allows DEA-registered practitioners to remotely prescribe Schedule II-V controlled medications, including certain narcotic medications for opioid use disorder treatment, without a prior in-person evaluation.

WV Board of Pharmacy CSMP Modernization to RxGov System

The West Virginia Board of Pharmacy is modernizing its Controlled Substances Monitoring Program (CSMP) by transitioning from the CSAPP platform to the RxGov system. This upgrade aims to improve performance, data quality, and reporting capabilities. Key transition dates are outlined, with a full cutover expected in early March 2026.

Louisiana Board of Pharmacy Office Closure Due to Hurricane Nicholas

The Louisiana Board of Pharmacy announced the closure of its state office on September 15, 2021, due to anticipated severe weather from Hurricane Nicholas. The office is expected to reopen for business, though not for visitors, on September 16, 2021, unless the closure order is extended.

Louisiana Pharmacy Credential Renewal Notice

The Louisiana Board of Pharmacy has issued a notice regarding the credential renewal cycle for pharmacists and pharmacies. The renewal period for licenses and permits will be open from November 1 to December 31, 2021, with options for online or paper applications.

Louisiana Board of Pharmacy Office Closure due to Hurricane Ida

The Louisiana Board of Pharmacy announced an extension of its office closure due to Hurricane Ida, now through September 5, 2021. The office will remain closed to visitors due to staffing impacts from COVID-19, with materials to be deposited via mail slot or submitted electronically.

Louisiana Board of Pharmacy Office Reopens to Business, Remains Closed to Public

The Louisiana Board of Pharmacy has reopened its office for business following Hurricane Ida closures. However, due to insufficient staffing, the office remains closed to public visitors. Deliveries can be made via the mail slot, and inquiries should be directed to the general email address.

Louisiana Board of Pharmacy Office Closure Due to COVID-19

The Louisiana Board of Pharmacy announced its office is closed to visitors effective immediately due to COVID-19 illness impacting staff levels. Licensees and applicants are directed to use mail or email for submissions and inquiries, as phone lines are on auto-attendant.

Florida MQA releases 2025-26 Q2 performance report

Florida MQA releases 2025-26 Q2 performance report

Mississippi Board of Pharmacy Final Rule Effective

The Mississippi Board of Pharmacy has filed a final administrative rule with the Secretary of State. This rule will become effective on March 13, 2026, impacting healthcare providers within the state.

Contract Award for Pharmacy Professionals Recovery Services

The Mississippi Board of Pharmacy has announced a contract award for pharmacy professionals recovery services. This notice serves to inform stakeholders about the selection of a service provider to offer support and resources for pharmacy professionals facing substance abuse or other challenges.

MEAC Medical Equipment Advisory Committee Meeting Announcement

The Mississippi Board of Pharmacy has announced a meeting for the Medical Equipment Advisory Committee (MEAC) on December 2, 2025. The meeting will cover topics related to medical equipment and is scheduled to take place at the Board's office in Jackson, Mississippi.

MS Board of Pharmacy Accepting Applications for 2 Positions

The Mississippi Board of Pharmacy is seeking applications for two positions: a Compliance Agent and a Staff Attorney. The job posting for the Compliance Agent will remain open until February 4, 2026, and includes statewide field work. The Staff Attorney position requires at least five years of legal experience and familiarity with administrative law.

MS Board of Pharmacy Resolution for State of Emergency Ice Storm

The Mississippi Board of Pharmacy has issued a resolution acknowledging the state of emergency due to an ice storm. This resolution outlines temporary measures and guidance for pharmacies to ensure continued patient access to medications during the emergency period.

SC Board of Pharmacy: Revised Vaccine Administration Protocol

The South Carolina Board of Pharmacy has revised its protocol for vaccine administration by pharmacists, effective September 17, 2025. The primary change allows pharmacists, interns, and technicians to administer FDA-approved COVID-19 vaccines without a practitioner's order, following specific professional recommendations.

Idaho Pharmacy Board: Ivermectin OTC Update

The Idaho Board of Pharmacy has issued an update regarding the over-the-counter availability of Ivermectin. This notice clarifies regulatory standing following legislative changes, referencing Senate Bill 1211.

Idaho Board of Pharmacy Grants Medication Authority to Naturopaths

The Idaho Board of Pharmacy has announced that naturopaths are now granted medication authority. This change expands the scope of practice for licensed naturopathic physicians in Idaho, allowing them to prescribe certain medications.

Idaho Pharmacy Licensure Renewal Cycle and Fee Updates

The Idaho Board of Pharmacy is updating its licensure renewal cycles and fees effective July 1, 2025. Pharmacist licenses will now expire on the licensee's birthday, with renewals shifting to a two-year cycle, and associated fees will double for biennial renewals.